Faron Pharmaceuticals Current Valuation vs. EBITDA
| FARN Stock | 165.00 10.00 5.71% |
For Faron Pharmaceuticals profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Faron Pharmaceuticals to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Faron Pharmaceuticals Oy utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Faron Pharmaceuticals's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Faron Pharmaceuticals Oy over time as well as its relative position and ranking within its peers.
Faron |
Faron Pharmaceuticals EBITDA vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Faron Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Faron Pharmaceuticals value to that of its competitors to determine the firm's financial worth. Faron Pharmaceuticals Oy is rated as one of the top companies in current valuation category among its peers. It also is one of the top stocks in ebitda category among its peers . At this time, Faron Pharmaceuticals' EBITDA is comparatively stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Faron Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Faron Current Valuation vs. Competition
Faron Pharmaceuticals Oy is rated as one of the top companies in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is currently estimated at about 95.46 Trillion. Faron Pharmaceuticals adds roughly 168.84 Million in current valuation claiming only tiny portion of equities under Health Care industry.
Faron EBITDA vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Faron Pharmaceuticals |
| = | 168.84 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Faron Pharmaceuticals |
| = | (28.37 M) |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Faron EBITDA Comparison
Faron Pharmaceuticals is currently under evaluation in ebitda category among its peers.
Faron Pharmaceuticals Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Faron Pharmaceuticals, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Faron Pharmaceuticals will eventually generate negative long term returns. The profitability progress is the general direction of Faron Pharmaceuticals' change in net profit over the period of time. It can combine multiple indicators of Faron Pharmaceuticals, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 154.4 K | 162.1 K | |
| Operating Income | -28.6 M | -27.1 M | |
| Income Before Tax | -30.9 M | -29.4 M | |
| Total Other Income Expense Net | -2.4 M | -2.3 M | |
| Net Loss | -30.9 M | -29.4 M | |
| Income Tax Expense | 1.5 M | 1.6 M | |
| Net Loss | -30.9 M | -29.4 M | |
| Net Loss | -25.9 M | -24.6 M | |
| Net Interest Income | -2.4 M | -2.3 M | |
| Interest Income | 230 K | 125 K | |
| Change To Netincome | 771.6 K | 399.3 K |
Faron Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Faron Pharmaceuticals. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Faron Pharmaceuticals position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Faron Pharmaceuticals' important profitability drivers and their relationship over time.
Use Faron Pharmaceuticals in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Faron Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Faron Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Faron Pharmaceuticals Pair Trading
Faron Pharmaceuticals Oy Pair Trading Analysis
The ability to find closely correlated positions to Faron Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Faron Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Faron Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Faron Pharmaceuticals Oy to buy it.
The correlation of Faron Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Faron Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Faron Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Faron Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Faron Pharmaceuticals position
In addition to having Faron Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Warren Buffett Holdings Thematic Idea Now
Warren Buffett Holdings
A long-term portfolio of publicly-traded stocks on US exchanges that are owned by Warren Buffett's holding company Berkshire Hathaway. The Warren Buffett Holdings theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Warren Buffett Holdings Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Faron Stock Analysis
When running Faron Pharmaceuticals' price analysis, check to measure Faron Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Faron Pharmaceuticals is operating at the current time. Most of Faron Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Faron Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Faron Pharmaceuticals' price. Additionally, you may evaluate how the addition of Faron Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.